Search results for:
valproic acid
valproic acid
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Depakene |
CAPSULE, ORAL |
250 mg |
|
|
|
|
| Stavzor |
DELAYED RELEASE CAPSULE, ORAL |
125 mg, 250 mg, 500 mg |
|
|
|
|
| Depacon, Valproate Sodium |
SOLUTION, INTRAVENOUS |
100 mg/mL |
|
|
|
|
| Depakene |
SYRUP, ORAL |
250 mg/5 mL |
|
|
|
|
Last updated: Aug. 20, 2026
ORDERED FORMULATION
FORMULARY INTERCHANGE
valproic acid (Stavzor)
divalproex sodium (Depakote)
Adults: valproate sodium doses 500 mg or less may be given undiluted as an IVP over 1-2 minutes. Doses greater than 500 mg are to be administered IVPB in 100 mL NS or D5W over 15 minutes.
Depakene medication guide
Stavzor medication guide
STAVZOR is a delayed-release valproic acid product similar to DEPAKOTE delayed-release and its generics. It is classified as non-formulary, not stocked. Interchange to a generic DEPAKOTE product on a mg:mg basis.
Reviewed: June 24, 2008 (STAVZOR)